Blade Q1 revenue up 70% to $45.3M; Flight Profit +145% to $7.2M

Strata Critical Medical, Inc.

2023-Q1 EPS reported -$0.14 revenue$45,271,000

Short Distance revenue rose 148% YoY, driven by Blade Europe acquisition, Canada improvement, and Airport demand.
MediMobility Organ Transport revenue up 111% YoY and 24% sequentially, from new transplant centers and existing client growth.
Flight Profit (non-GAAP) increased 145% to $7.2M; company cites leverage and expects YoY Adjusted EBITDA improvement.
Seventh consecutive quarter with results ahead of expectations; no GAAP net income or EPS disclosed in release.
Management highlights strong liquidity and asset-light model, preserving capital for opportunistic acquisitions.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

Strata Critical Medical, Inc. reported financial results for the first quarter ended March 31, 2023.

Period: the first quarter ended March 31, 2023
Result: reported results

Exact text from the filing

On May 11, 2023, Blade Air Mobility, Inc. (“Blade”) issued a press release announcing its financial results for the first quarter ended March 31, 2023.

View on SEC.gov

Browse all earnings releases →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001779128-23-000049

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.